82239-20-1 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
2,3-DICHLOROPHENYL-4-NITROPHENYL ETHER is used as a chemical intermediate for the synthesis of various pharmaceuticals and agrochemicals, contributing to the development of new drugs and pesticides. Its role in these industries is crucial for creating effective treatments and protection agents against pests and diseases.
Used in Research and Development:
In the scientific community, 2,3-DICHLOROPHENYL-4-NITROPHENYL ETHER is utilized in research and development for studying its chemical properties and potential applications. This includes understanding its reactivity, stability, and mutagenicity, which are essential for safe and effective use in various chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 82239-20-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,2,3 and 9 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 82239-20:
(7*8)+(6*2)+(5*2)+(4*3)+(3*9)+(2*2)+(1*0)=121
121 % 10 = 1
So 82239-20-1 is a valid CAS Registry Number.
InChI:InChI=1/C12H7Cl2NO3/c13-10-2-1-3-11(12(10)14)18-9-6-4-8(5-7-9)15(16)17/h1-7H
82239-20-1Relevant academic research and scientific papers
Synthesis and biological activity of 2-(trifluoromethyl)-1H-benzimidazole derivatives against some protozoa and Trichinella spiralis
Hernández-Luis, Francisco,Hernández-Campos, Alicia,Castillo, Rafael,Navarrete-Vázquez, Gabriel,Soria-Arteche, Olivia,Hernández-Hernández, Manuel,Yépez-Mulia, Lilián
experimental part, p. 3135 - 3141 (2010/09/03)
A series of 2-(trifluoromethyl)-1H-benzimidazole derivatives (1ae1i) were synthesized via Phillips cyclocondensation of a substituted 1,2-phenylenediamine and trifluoroacetic acid. The synthesized compounds were evaluated in vitro against various protozoan parasites: Giardia intestinalis, Entamoeba histolytica, Trichomonas vaginalis and Leishmania mexicana, and they showed nanomolar activities against the first three protozoa tested. The compounds were also tested in vitro and in vivo against the nematode Trichinella spiralis. Compounds 1b, 1c and 1e had the most desirable in vitro antiparasitic profile against all parasites studied. In the in vivo model against T. spiralis, compounds 1b and 1e showed good activity against the adult phase at 75 mg/Kg. However, against the muscle larvae stage, only compound 1f exhibited in vivo antiparasitic efficacy.
